Risperidone for attention-deficit hyperactivity disorder in people with intellectual disabilities.

@article{Thomson2009RisperidoneFA,
  title={Risperidone for attention-deficit hyperactivity disorder in people with intellectual disabilities.},
  author={Alex Thomson and Stefanos Maltezos and Elena Paliokosta and Kiriakos I. Xenitidis},
  journal={The Cochrane database of systematic reviews},
  year={2009},
  volume={2},
  pages={
          CD007011
        }
}
BACKGROUND Attention deficit hyperactivity disorder (ADHD) is increasingly recognised as occurring in people with intellectual disability (ID), although treatment of ADHD in this population has not ben tested widely. Risperidone has been used to treat ADHD in people with ID, although the evidence for its effectiveness is unclear. OBJECTIVES To examine the effectiveness of risperidone for the treatment of attention deficit hyperactivity disorder in people with intellectual disabilities… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-8 OF 8 CITATIONS

Attention Problems and Parent-Rated Behavior and Stress in Young Children at Risk for Developmental Delay

VIEW 2 EXCERPTS
CITES BACKGROUND

References

Publications referenced by this paper.
SHOWING 1-10 OF 68 REFERENCES

Personal correspondence. Email to Alex Thomson from Carin Binder (28 October 2008) clarifying reasons why two studies of Risperidal did not meet inclusion criteria for this review

  • C. Binder
  • 2008
VIEW 1 EXCERPT

published data

  • JL Armenteros, JE Lewis, M. Davalos
  • Armenteros
  • 2007

The influence of risperidone on attentional functions in children and adolescents with attention-deficit/hyperactivity disorder and co-morbid disruptive behavior disorder

  • T Günther, B Herpertz-Dahlmann, J Jolles, K. Konrad
  • Journal of Child and Adolescent Psychopharmacology
  • 2006

Croonenberghs 2005) and one study was a series of case reports

  • Correia Filho
  • (Dartnall
  • 2005